Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
Liu Y, Ho C, Yu W, Huang Y, Miller J, Gao Q, Syed M, Ma Y, Wang M, Maciag L, Petrova-Drus K, Zhu M, Yao J, Vanderbilt C, Durham B, Benhamida J, Ewalt MD, Dogan A, Roshal M, Nafa K, Arcila ME.
Liu Y, et al. Among authors: vanderbilt c.
J Mol Diagn. 2024 Mar;26(3):168-178. doi: 10.1016/j.jmoldx.2023.11.009. Epub 2023 Dec 14.
J Mol Diagn. 2024.
PMID: 38103591
Free article.